Drug Facts

Manufacturer
Haleon US Holdings LLC | PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC
Effective date
2026-08-20
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
daily-update
Hydrated at
2026-08-22 01:01:11

Label at a glance#

ProductAdvil Menstrual Pain
Active ingredientIBUPROFEN SODIUM
Label structure10 sections

Indications and uses

temporarily relieves minor aches and pains due to: menstrual cramps backache headache muscular aches the common cold toothache minor pain of arthritis temporarily reduces fever

Dosage and administration

do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be used do not exceed 6 tablets in 24 hours, unless directed by a doctor children under 12 years: ask a doctor

Storage and handling

each tablet contains: sodium 22 mg read all warnings and directions before use. Keep carton. store at 20-25°C (68-77°F) avoid excessive heat above 40°C (104°F)

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ibuprofen 200 mg (provided as ibuprofen sodium 256 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Purpose

OTC - PURPOSE SECTION

Pain reliever/Fever reducer

Uses

INDICATIONS & USAGE SECTION

  • temporarily relieves minor aches and pains due to:
    • menstrual cramps
    • backache
    • headache
    • muscular aches
    • the common cold
    • toothache
    • minor pain of arthritis
  • temporarily reduces fever

Warnings

WARNINGS SECTION

Allergy alert:

SPL UNCLASSIFIED SECTION

Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

  • hives
  • facial swelling
  • asthma (wheezing)
  • shock
  • skin reddening
  • rash
  • blisters

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning:

SPL UNCLASSIFIED SECTION

This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

  • are age 60 or older
  • have had stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others]
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Heart attack and stroke warning:

SPL UNCLASSIFIED SECTION

NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

OTC - DO NOT USE SECTION

  • if you have ever had an allergic reaction to any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

  • stomach bleeding warning applies to you
  • you have problems or serious side effects from taking pain relievers or fever reducers
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke
  • you are taking a diuretic

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • under a doctor's care for any serious condition
  • taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin
  • taking any other drug

When using this product

OTC - WHEN USING SECTION

  • take with food or milk if stomach upset occurs

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience any of the following signs of stomach bleeding:
    • feel faint
    • vomit blood
    • have bloody or black stools
    • have stomach pain that does not get better
  • you have symptoms of heart problems or stroke:
    • chest pain
    • trouble breathing
    • weakness in one part or side of body
    • slurred speech
    • leg swelling
  • pain gets worse or lasts more than 10 days
  • fever gets worse or lasts more than 3 days
  • redness or swelling is present in the painful area
  • any new symptoms appear

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not take more than directed
  • the smallest effective dose should be used
  • adults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persist
  • if pain or fever does not respond to 1 tablet, 2 tablets may be used
  • do not exceed 6 tablets in 24 hours, unless directed by a doctor
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each tablet contains: sodium 22 mg
  • read all warnings and directions before use. Keep carton.
  • store at 20-25°C (68-77°F)
  • avoid excessive heat above 40°C (104°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

acesulfame potassium, caramel color, carnauba wax, colloidal silicon dioxide, copovidone, ferric oxide, hypromellose, mannitol, medium-chain triglycerides, microcrystalline cellulose, natural and artificial flavor, pharmaceutical ink, polyethylene glycol, propylene glycol, sodium lauryl sulfate, sucralose, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Call weekdays 9 AM to 5 PM EST at 1-800-88-ADVIL

Additional Information

SPL UNCLASSIFIED SECTION

Do Not Use if seal under bottle cap imprinted with

“SEALED for YOUR PROTECTION” is broken or missing.

READ AND KEEP CARTON FOR COMPLETE

WARNINGS AND INFORMATION

For most recent product information, visit www.Advil.com

Dist. by: GSK CH, Warren, NJ 07059 ©2021 GSK or licensor

Trademarks owned or licensed by GSK Patents: www.productpats.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0573-0230-20

Advil

menstrual
PAIN

FILM-COATED
IBUPROFEN
SODIUM

Ibuprofen Tablets, 200 mg
(Provided as Ibuprofen Sodium 256 mg)
Pain Reliever / Fever Reducer (NSAID)

Advil Tablets

20 Tablets

000068432 Front Carton

Advil Menstrual Tablets 20 ct
Advil Menstrual Tablets 20 ct

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
16cde546-8deb-4df2-a072-dab5566ede95Product name120231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015Product name420230808
874f4e63-49d2-5150-5d77-052172814ebdProduct name620230105
557673c2-8256-b351-e863-4ec71a5a64b0Product name220160714
dbc9a339-6215-4e94-9546-57a3b34902ceProduct name120160517
61c18d4e-b552-5478-8fc0-df38b93e3100Product name120140508
7b2938c9-7eb7-e312-ae90-f54f4240361eProduct name120140508
997601aa-bb5f-6971-6b90-a21132c12c7bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0573-0230-202024-01-31C16284748780-11030e365-4a7f-111a-e063-dadaa90a10e2Drug Facts
0573-0230-202024-01-31C16284748780-11030e365-4a7f-111a-e063-dadaa90a10e2Drug Facts
0573-0230-402024-01-31C16284748780-11030e365-4a7f-111a-e063-dadaa90a10e2Drug Facts
0573-0230-402024-01-31C16284748780-11030e365-4a7f-111a-e063-dadaa90a10e2Drug Facts

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0573-02300573-0230-20, 0573-0230-40

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML · Source PDF

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
62024-01-31full-release2026-06-01 00:08:10

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N201803-001ADVILIBUPROFEN SODIUMEQ 200MG BASETABLET / ORALRLD, RS2012-06-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1284e616aacf4f…
2026-08-18 06:07:402026-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1287673890dc5c…
2021-03-12 10:30 UTC2021-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-128869cabd3fbd…
2020-11-12 02:37 UTC2020-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12c0c555d07b60…
2019-12-14 00:12 UTC2019-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123f01610625f2…
2019-09-15 20:21 UTC2019-09N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12b00525d2431f…
2019-07-19 19:46 UTC2019-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123f0d92c62455…
2023-05-13 08:27 UTC2023-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12053a50430f4f…
2023-01-26 05:58 UTC2023-01N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Advil Menstrual PainIBUPROFEN SODIUMHaleon US Holdings LLCae1625f4-ef32-4d4f-bf54-c44085843e412026-08-20WarningsExact identifier
ndc (package): 0573-0230-40
ndc (package): 0573-0230-20
ndc (product): 0573-0230
ndc11 (package): 00573023040
ndc11 (package): 00573023020
spl id: 597d1b09-7a67-67b9-e063-6394a90aa0bd
spl set id: ae1625f4-ef32-4d4f-bf54-c44085843e41

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.